DCGO NASDAQ Week ended 11 Sep 2026

Weekly Investor Report

DocGo Inc · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 0.3523 USD
-12.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -40.4% below the Trend Line and sits at 0.6% of its 52-week range. The latest completed week returned -12.5%, after a -47.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 36/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 51d.

Setup score 17 out of 100
Latest Close 0.3523 USD 11 Sep 2026
1W Return -12.5% latest completed week
4W Return -47.2% short-term follow-through
12W Return -32.7% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -12.5% Latest completed week; four-week move -47.2%. Indicator stack 0/38 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 36/100 conviction; expected move 57.5%. News sentiment 50/100 4 relevant articles in the latest sentiment read. Event risk 51d Next report is scheduled for 09 Nov 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -40.4% below the Trend Line and sits at 0.6% of its 52-week range. The latest completed week returned -12.5%, after a -47.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug 4 Sep 11 Sep
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0912-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -47.2% over four weeks, -32.7% over 12 weeks, and -77.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-12.5%
4W-47.2%
12W-32.7%
26W-46.4%
52W-77.0%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.19Latest activity-pressure read.
Pressure change-112.0%Four-week change in activity pressure.
Leadership-59.50Latest relative-leadership reading.
RS change-73.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 11 Sep 2026 Financial statements through 30 Jun 2026 Field coverage 82% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength21/100Blend of value, momentum, and quality. Underlying universe rank 80; rank 1 is best.
Value36/100Relative valuation strength. Underlying universe rank 65; rank 1 is best.
Quality34/100Profitability and accounting quality. Underlying universe rank 67; rank 1 is best.
Momentum36/100Medium-term price momentum. Underlying universe rank 65; rank 1 is best.
Growth36/100Revenue and earnings growth. Underlying universe rank 65; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-46.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
30.1%
Gross profit retained from each unit of revenue.
Operating margin
-37.7%
Operating profit retained from revenue.
Free-cash-flow margin
-9.2%
Free cash flow generated from revenue.
Return on invested capital
-69.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-32.4%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-133.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

DCGO shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.33, expected move of 57.5%, and Sharemaestro trend signal inactive.

Conviction36/100
Expected move57.5%
Put/call volume0.33
Pressure62
Speculation0
Volatility96
Trend agreement0
Open options detail
Insider activity0 / 1

0 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

0 positive · 4 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings51dNext report is scheduled for 09 Nov 2026; event risk rises as the date approaches.
Options expected move57.5%Nearest-chain priced movement where available.
52-week drawdown-78.6%Distance below the 52-week high.
13-week volatility12.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+24.8%Week of 17 Apr.
Worst week-34.9%Week of 21 Aug.
Latest week-12.5%Week of 11 Sep.

Shape of recent returns

Strong gains9
Modest gains4
Flat weeks0
Modest losses2
Sharp losses11
Recent vol12.4%13-week weekly-return volatility.
Base vol9.2%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew5.6% / -8.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape19/100

Trend, activity pressure, participation, and risk combine to a 19/100 tape read.

 Indicator analysis29/100

Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.09; No reversal markers Factors30/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 92; Buyback Yield rank 56 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options39/100

DCGO shows bullish options pressure with a 36/100 conviction score, put-call volume ratio of 0.33, expected move of 57.5%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 57.5% Sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

DocGo at Morgan Stanley healthcare conference: margin push takes center stage Insiders0 / 1

0 acquisitions and 1 disposals in the latest 180-day insider tape.

 Earnings51d

Next report is scheduled for 09 Nov 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
11 Sep 20260.3523 USD-12.5%0.5913 USD2.59 USD-0.19-59.502.7MOff
4 Sep 20260.4027 USD1.3%0.6044 USD2.62 USD0.49-55.462.6MOff
28 Aug 20260.3975 USD-8.5%0.6169 USD2.66 USD1.03-57.316.3MOff
21 Aug 20260.4345 USD-34.9%0.6292 USD2.72 USD1.45-54.6110.4MOff
14 Aug 20260.6674 USD5.2%0.6428 USD2.77 USD1.58-34.242.7MOff
7 Aug 20260.6342 USD-2.5%0.6483 USD2.82 USD1.56-38.441.6MOff
31 Jul 20260.6506 USD9.2%0.6569 USD2.88 USD1.58-35.261.9MOff
24 Jul 20260.5958 USD-8.5%0.6648 USD2.94 USD1.47-41.512.3MOff
17 Jul 20260.6512 USD9.1%0.6759 USD2.99 USD1.39-38.463.1MOff
10 Jul 20260.597 USD7.5%0.6838 USD3.04 USD1.18-47.013.3MOff
3 Jul 20260.5556 USD13.4%0.6946 USD3.10 USD1.10-50.932.3MOff
26 Jun 20260.49 USD-6.4%0.711 USD3.15 USD1.13-57.4216.1MOff
19 Jun 20260.5236 USD-9.7%0.729 USD3.20 USD1.22-57.673.4MOff
12 Jun 20260.5796 USD3.6%0.7438 USD3.26 USD1.31-53.142.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context